BX Swiss TOP 30 CHF
1.370,99
PKT
+10,88
PKT
+0,80
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 11.07.16 | Swiss Re buy | HSBC | |
| 08.07.16 | Richemont Equal-Weight | Morgan Stanley | |
| 08.07.16 | Nestlé overweight | Barclays Capital | |
| 07.07.16 | Swiss Re Underperform | BNP PARIBAS | |
| 07.07.16 | Roche Hold | Kepler Cheuvreux | |
| 07.07.16 | Novartis buy | Kepler Cheuvreux | |
| 06.07.16 | Swiss Re overweight | JP Morgan Chase & Co. | |
| 06.07.16 | Richemont kaufen | Independent Research GmbH | |
| 06.07.16 | Novartis Halten | Independent Research GmbH | |
| 06.07.16 | UBS Outperform | Macquarie Research | |
| 06.07.16 | UBS Underperform | Macquarie Research | |
| 04.07.16 | UBS Verkaufen | Independent Research GmbH | |
| 04.07.16 | Nestlé overweight | JP Morgan Chase & Co. | |
| 04.07.16 | UBS Underperform | BNP PARIBAS | |
| 04.07.16 | UBS Underperform | BNP PARIBAS | |
| 04.07.16 | Holcim buy | Deutsche Bank AG | |
| 01.07.16 | Nestlé kaufen | Kepler Cheuvreux | |
| 01.07.16 | Richemont Hold | Société Générale Group S.A. (SG) | |
| 01.07.16 | Roche overweight | JP Morgan Chase & Co. | |
| 01.07.16 | Richemont Neutral | JP Morgan Chase & Co. | |
| 01.07.16 | Zurich Insurance overweight | JP Morgan Chase & Co. | |
| 01.07.16 | Roche buy | Citigroup Corp. | |
| 30.06.16 | UBS Halten | Independent Research GmbH | |
| 30.06.16 | UBS Equal-Weight | Morgan Stanley | |
| 30.06.16 | UBS Equal-Weight | Morgan Stanley | |
| 30.06.16 | Givaudan overweight | JP Morgan Chase & Co. | |
| 30.06.16 | Nestlé overweight | JP Morgan Chase & Co. | |
| 30.06.16 | Roche buy | Jefferies & Company Inc. | |
| 30.06.16 | Holcim Equal weight | Barclays Capital | |
| 30.06.16 | Nestlé Hold | HSBC | |
| 30.06.16 | Givaudan neutral | Kepler Cheuvreux | |
| 30.06.16 | Richemont buy | Kepler Cheuvreux | |
| 30.06.16 | Nestlé Underperform | Macquarie Research | |
| 30.06.16 | Richemont Outperform | BNP PARIBAS | |
| 29.06.16 | UBS buy | UBS AG | |
| 29.06.16 | ABB (Asea Brown Boveri) Sell | Goldman Sachs Group Inc. | |
| 29.06.16 | Richemont Neutral | Goldman Sachs Group Inc. | |
| 29.06.16 | Holcim buy | Goldman Sachs Group Inc. | |
| 29.06.16 | Swiss Re buy | HSBC | |
| 29.06.16 | Zurich Insurance overweight | Barclays Capital |